ArticleClinical ophthalmology (Auckland, N.Z.)2023

One-Year Outcomes of Faricimab Treatment for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration.

Ryan B RushPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.